Sun Pharma’s arm enters into anti-fungal powder OTC category with ABZORB

30 Apr 2018 Evaluate

Sun Pharma Consumer Healthcare (CHC), a division of Sun Pharmaceutical Industries has entered into the anti-fungal powder OTC category with ABZORB. The brand will be co-promoted across prescription & OTC channels in India to drive growth. Sun Pharma CHC has launched a 360 degree marketing campaign comprising TV, print & digital to expand consumer outreach.

ABZORB’s unique combination of talc & starch ensures superior sweat absorption and clotrimazole, one of the best-in-class anti-fungal, helps treat infection & prevents its recurrence. The new packaging design, with an angular dispensing nozzle, enhances consumer experience through targeted application. The new pack makes it easier to apply the product on difficult to reach areas thereby reducing wastage. The product is available in 100 g & 50 g packaging.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharma Inds. Share Price

1631.65 -2.75 (-0.17%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×